Feuerstein's Biotech Mailbag

Mar 10, 2007 Read more: TheStreet.com
Mail call! This the column where I answer reader mail on all things biotech. Thanks for writing in and keep those emails coming . Read more
Robert Josey

Sugar Land, TX

#1 Mar 25, 2007
Dear Adam,
I like your articles and read them regularly. Thank you for being very informative. Do you believe the recent sell off in Vertex Pharmaceuticals is a good buying opportunity? The chances of success with the Hep C drug being tested seem to be quite strong based on past clincal trials. Are the chances of good test results coming out in April as strong as the previous results? Do you think this is a good time to buy shares in Vertex. I believe they closed on Friday around 28 dollars per share. Thank you. Robert
My email address is rajenergy@sbcglobal.net
Dave

Avon, CT

#2 Apr 27, 2009
Adam, how come you didn't report on HGSI's Achieve 2/3 from EASL?

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Vertex Pharmaceuticals Discussions

Title Updated Last By Comments
News Seaport parking becomes a hot commodity (Jun '14) Jun '14 Doug 1
News Vertex, Biogen make list of most productive dru... (Jun '14) Jun '14 Doug 1
News Vertex to Present at the Goldman Sachs Global H... (Jun '14) Jun '14 Doug 1
News Price of cystic fibrosis drug Kalydeco could dr... (Jun '14) Jun '14 Doug 1
News Alberta health minister to take on U.S. company... (Jun '14) Jun '14 Doug 1
News Sold: Joe Fallon's two Vertex buildings on Fan ... (Jun '14) Jun '14 Lori 1
News Alberta minister asks for fair price for U.S. c... (Jun '14) Jun '14 Lori 1
More from around the web